Eris Lifesciences Ltd

*Eris Lifesciences Ltd.*

C&H Formation on Yearly Basis.
C&H Price Trendline BreakOut. Should Sustain.
Major Resistance at 820/849. Once Crosses / Sustains. Then Good to Go.
RSI: 1H < D>W>M

Note: Promoters Pledge at 11.4%
Forayed in Dermatology in FY22.
Acquired Domestic Formulations business of Strides.
Acquired Brands from Glenmark & DRL.
Spike in Debt.

Trail SL with Upside.
Book Profit as per Risk Appetite.

Do Your Own Research as well. This is an Opinion.
Happy Investing 😇